共 50 条
- [24] TOXICITY FROM RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR (RHUGM-CSF) AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 53 - 53
- [27] THE USE OF RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 : S15 - S18
- [29] Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies BONE MARROW TRANSPLANTATION, 1996, 17 (06) : 951 - 956